| 000 | 01941cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030736.0 | ||
| 008 | 130110s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2012.Sh.P | ||
| 100 | 0 | _aShereen Shaker Elhusseny Ahmed | |
| 245 | 1 | 0 |
_aPrepation of membrane - based systems useful in delivering biologically active materials to skin / _cShereen Shaker Elhusseny Ahmed ; Supervised Aliaa Abdellatif Badawi , Hanan Mohammed Ellaithy , Demiana Ibrahim Nesseem |
| 246 | 1 | 5 | _aتحضير أغشية لاستخدامها كأنظمة لانطلاق المواد الحيوية الى الجلد |
| 260 |
_aCairo : _bShereen Shaker Elhusseny Ahmed , _c2012 |
||
| 300 |
_a200P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aThecurrent work has aimed to improve HA therapy in knee OA by developing a novel combined controlled transdermal membrane therapy containing both HA and KT . In this way , easy , painless and continuous HA - KT delivery through the skin into the blood stream could be ensured thus produce stable plasma concentration over a long period and avoiding invasive frequent HA intra - articular injections and KT gastrointestinal complaints associated with all NSAIDs such as bleeding , perforation and peptic ulceration | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBone mineral density (BMD) | |
| 653 | 4 | _aFreund's complete adjuvant (FCA) | |
| 653 | 4 | _aHyaluronic acid (HA) | |
| 700 | 0 |
_aAliaa Abdellatif Badawi , _eSupervisor |
|
| 700 | 0 |
_aDemiana Ibrahim Nesseem , _eSupervisor |
|
| 700 | 0 |
_aHanan Mohammed Ellaithy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40990 _d40990 |
||